A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 7, 2013, Pages

  Barak, Mira ^a   Rozenberg, Orit ^a   Grinberg, Maya ^a   Reginashvili, Dina ^a   Kishinewsky, Maya ^a   Henig, Clara ^a   Froom, Paul ^a  

^a CLALIT HEALTH SERVICES   (Israel)

Author keywords

algorithm; antinuclear antibodies (ANA); autoimmune diseases; cost; immunofluorescence assay (IFA)

Indexed keywords

ANTINUCLEAR ANTIBODY;

ALGORITHM; AUTOIMMUNE DISEASE; AUTOMATION; CONJUGATION; COST EFFECTIVENESS ANALYSIS; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; GOLD STANDARD; HEP 2 CELL; HUMAN; IMMUNOFLUORESCENCE TEST; LETTER; MEDICAL STAFF; OUTPATIENT; PREMATURITY; PRIORITY JOURNAL; SOLID; VISUAL SYSTEM;

ALGORITHMS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; COST-BENEFIT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; OUTPATIENTS; SENSITIVITY AND SPECIFICITY;

EID: 84883025677     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0535     Document Type: Letter

References (10)

1. Meroni PL, Schur PH. ANA screening: An old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
2. Wiik AS, Høier-Madsen M, Forslid J, Charles P, Meyrowitsch J. Antinuclear antibodies: A contemporary nomenclature using HEp-2 cells. J Autoimmun 2010;35:276-90.
3. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011;63: 191-200.
4. Nossent H, Rekvig OP. Antinuclear antibody screening in this new millennium: Farewell to the microscope ? Scand J Rheumatol 2001;30:123-6. (Pubitemid 32476914)
5. Fenger M, Wiik A, Høier-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004;50:2141-7. (Pubitemid 39425853)
6. Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods 2006;311:189-97.
7. Hanly JG, Su L, Farewell V, Fritzler MJ. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010;358:75-80.
8. Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010;352:147-52.
9. Russell AS, Johnston C. Relative value of commercial kits for ANA testing. Clin Exp Rheumatol 2003;21:477-80. (Pubitemid 36950317)
10. Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: A statistical analysis. Am J Clin Pathol 2011;135:678-84.